Company / R&D per Share
Inhibrx Biosciences, Inc. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$7.81
FY2025
5-year range
$4.05 / $16.26
FY2023-FY2025
Trend
+93.0%
vs FY2024
Sector context
#23 of 208
Health Care
What the data says
Inhibrx Biosciences, Inc.'s r&d per share of $7.81 is higher than 89% of companies in the Health Care sector (FY2025). Declined from $16.26 to $7.81 over the past 2 years.
Based on SEC 10-K filings.
7.81 in FY2025. Top quartile in the Health Care sector.
Declined from $16.26 to $7.81 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 208This company $7.81 Sector average $28.82
▼
-72.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 93.0% year-over-year.
- Ranks #23 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.81 | +93.0% |
| FY2024 | $4.05 | -75.1% |
| FY2023 | $16.26 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026